Related Experiment Videos
[Stereotactic tumor biopsy and tumor excision]
K J Winzer1, S Filimonow, H Guski
1Klinik für Allgemein-, Viszeral-, Gefäss- und Thoraxchirurgie, Medizinische Fakultät, Humboldt-Universität zu Berlin.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|February 5, 1999
Summary
The ABBI system facilitates stereotactic procedures for nonpalpable breast lesions, including tissue resection for diagnosis and potential lumpectomy. However, it cannot treat lesions near the chest wall or behind the nipple.
Area of Science:
- Radiology and Imaging
- Breast Surgery
- Pathology
Context:
- Stereotactic procedures are crucial for diagnosing nonpalpable breast lesions identified via mammography.
- The ABBI system integrates various biopsy techniques and tissue resection under digital mammography guidance.
- Digital mammography is optimal for microcalcification detection but can struggle with opacification visualization.
Purpose:
- To evaluate the utility and application of the ABBI system in stereotactic breast procedures.
- To assess the effectiveness of cylindrical extirpation for diagnosing and treating small nonpalpable breast lesions.
- To determine the system's limitations, such as proximity to the thoracic wall or retromamillary location.
Summary:
- The ABBI system supports stereotactic needle biopsy, fine needle biopsy, and core needle biopsy for nonpalpable breast lesions.
- It allows for resection of cylindrical tissue specimens up to 20 mm, with cylindrical extirpation recommended for lesions ≤15 mm.
- This method can serve as a definitive lumpectomy in select cases, though certain lesion locations are contraindicated.
Impact:
- The ABBI system was utilized in 40.7% of patients undergoing procedures for nonpalpable breast lesions.
- Cylindrical extirpation offers a minimally invasive approach for diagnosis and potential definitive treatment of small breast lesions.
- Understanding the ABBI system's capabilities and limitations optimizes patient selection for stereotactic breast interventions.